MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma

Yusuke Yamamoto, Nobuyoshi Kosaka, Minoru Tanaka, Fumiaki Koizumi, Yae Kanai, Takayuki Mizutani, Yoshiki Murakami, Masahiko Kuroda, Atsushi Miyajima, Takashi Kato, Takahiro Ochiya

Research output: Contribution to journalArticle

161 Citations (Scopus)

Abstract

We identified that microRNA expression changed dynamically during liver development and found that miR-500 is an oncofetal miRNA in liver cancer. miR-500 was abundantly expressed in several human liver cancer cell lines and 45% of human hepatocellular carcinoma (HCC) tissue. Most importantly, an increased amount of miR-500 was found in the sera of the HCC patients. In fact, miR-500 levels in sera of the HCC patients returned to normal after the surgical treatment in three HCC patients. Our findings reveal that diverse changes of miRNAs occur during liver development and, one of these, miR-500 is an oncofetal miRNA relevant to the diagnosis of human HCC.

Original languageEnglish
Pages (from-to)529-538
Number of pages10
JournalBiomarkers
Volume14
Issue number7
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

MicroRNAs
Liver
Hepatocellular Carcinoma
Liver Neoplasms
Serum
Cells
Tissue
Cell Line
Therapeutics

Keywords

  • Hepatocellular carcinoma, liver development, diagnosis
  • miR-500
  • miRNA

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis

Cite this

Yamamoto, Y., Kosaka, N., Tanaka, M., Koizumi, F., Kanai, Y., Mizutani, T., ... Ochiya, T. (2009). MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers, 14(7), 529-538. https://doi.org/10.3109/13547500903150771

MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. / Yamamoto, Yusuke; Kosaka, Nobuyoshi; Tanaka, Minoru; Koizumi, Fumiaki; Kanai, Yae; Mizutani, Takayuki; Murakami, Yoshiki; Kuroda, Masahiko; Miyajima, Atsushi; Kato, Takashi; Ochiya, Takahiro.

In: Biomarkers, Vol. 14, No. 7, 2009, p. 529-538.

Research output: Contribution to journalArticle

Yamamoto, Y, Kosaka, N, Tanaka, M, Koizumi, F, Kanai, Y, Mizutani, T, Murakami, Y, Kuroda, M, Miyajima, A, Kato, T & Ochiya, T 2009, 'MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma', Biomarkers, vol. 14, no. 7, pp. 529-538. https://doi.org/10.3109/13547500903150771
Yamamoto Y, Kosaka N, Tanaka M, Koizumi F, Kanai Y, Mizutani T et al. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. Biomarkers. 2009;14(7):529-538. https://doi.org/10.3109/13547500903150771
Yamamoto, Yusuke ; Kosaka, Nobuyoshi ; Tanaka, Minoru ; Koizumi, Fumiaki ; Kanai, Yae ; Mizutani, Takayuki ; Murakami, Yoshiki ; Kuroda, Masahiko ; Miyajima, Atsushi ; Kato, Takashi ; Ochiya, Takahiro. / MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma. In: Biomarkers. 2009 ; Vol. 14, No. 7. pp. 529-538.
@article{4778c0c8e01346989f21a6796e98ee7c,
title = "MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma",
abstract = "We identified that microRNA expression changed dynamically during liver development and found that miR-500 is an oncofetal miRNA in liver cancer. miR-500 was abundantly expressed in several human liver cancer cell lines and 45{\%} of human hepatocellular carcinoma (HCC) tissue. Most importantly, an increased amount of miR-500 was found in the sera of the HCC patients. In fact, miR-500 levels in sera of the HCC patients returned to normal after the surgical treatment in three HCC patients. Our findings reveal that diverse changes of miRNAs occur during liver development and, one of these, miR-500 is an oncofetal miRNA relevant to the diagnosis of human HCC.",
keywords = "Hepatocellular carcinoma, liver development, diagnosis, miR-500, miRNA",
author = "Yusuke Yamamoto and Nobuyoshi Kosaka and Minoru Tanaka and Fumiaki Koizumi and Yae Kanai and Takayuki Mizutani and Yoshiki Murakami and Masahiko Kuroda and Atsushi Miyajima and Takashi Kato and Takahiro Ochiya",
year = "2009",
doi = "10.3109/13547500903150771",
language = "English",
volume = "14",
pages = "529--538",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma

AU - Yamamoto, Yusuke

AU - Kosaka, Nobuyoshi

AU - Tanaka, Minoru

AU - Koizumi, Fumiaki

AU - Kanai, Yae

AU - Mizutani, Takayuki

AU - Murakami, Yoshiki

AU - Kuroda, Masahiko

AU - Miyajima, Atsushi

AU - Kato, Takashi

AU - Ochiya, Takahiro

PY - 2009

Y1 - 2009

N2 - We identified that microRNA expression changed dynamically during liver development and found that miR-500 is an oncofetal miRNA in liver cancer. miR-500 was abundantly expressed in several human liver cancer cell lines and 45% of human hepatocellular carcinoma (HCC) tissue. Most importantly, an increased amount of miR-500 was found in the sera of the HCC patients. In fact, miR-500 levels in sera of the HCC patients returned to normal after the surgical treatment in three HCC patients. Our findings reveal that diverse changes of miRNAs occur during liver development and, one of these, miR-500 is an oncofetal miRNA relevant to the diagnosis of human HCC.

AB - We identified that microRNA expression changed dynamically during liver development and found that miR-500 is an oncofetal miRNA in liver cancer. miR-500 was abundantly expressed in several human liver cancer cell lines and 45% of human hepatocellular carcinoma (HCC) tissue. Most importantly, an increased amount of miR-500 was found in the sera of the HCC patients. In fact, miR-500 levels in sera of the HCC patients returned to normal after the surgical treatment in three HCC patients. Our findings reveal that diverse changes of miRNAs occur during liver development and, one of these, miR-500 is an oncofetal miRNA relevant to the diagnosis of human HCC.

KW - Hepatocellular carcinoma, liver development, diagnosis

KW - miR-500

KW - miRNA

UR - http://www.scopus.com/inward/record.url?scp=70449412171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449412171&partnerID=8YFLogxK

U2 - 10.3109/13547500903150771

DO - 10.3109/13547500903150771

M3 - Article

C2 - 19863192

AN - SCOPUS:70449412171

VL - 14

SP - 529

EP - 538

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 7

ER -